384 related articles for article (PubMed ID: 28250290)
1. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
[TBL] [Abstract][Full Text] [Related]
3. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
[TBL] [Abstract][Full Text] [Related]
4. IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.
Hagström H; Stål P; Hultcrantz R; Brismar K; Ansurudeen I
Scand J Gastroenterol; 2017 Dec; 52(12):1427-1434. PubMed ID: 28927302
[TBL] [Abstract][Full Text] [Related]
5. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
Stanley TL; Fourman LT; Zheng I; McClure CM; Feldpausch MN; Torriani M; Corey KE; Chung RT; Lee H; Kleiner DE; Hadigan CM; Grinspoon SK
J Clin Endocrinol Metab; 2021 Jan; 106(2):e520-e533. PubMed ID: 33125080
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
[TBL] [Abstract][Full Text] [Related]
8. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.
Dichtel LE; Corey KE; Haines MS; Chicote ML; Kimball A; Colling C; Simon TG; Long MT; Husseini J; Bredella MA; Miller KK
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3624-e3632. PubMed ID: 35779256
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.
Ikarashi Y; Kodama K; Taniai M; Hashimoto E; Tokushige K
Intern Med; 2018 Apr; 57(8):1065-1070. PubMed ID: 29269684
[TBL] [Abstract][Full Text] [Related]
10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
11. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver.
Takahashi Y
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678199
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
14. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Osganian SA; Subudhi S; Masia R; Drescher HK; Bartsch LM; Chicote ML; Chung RT; Gee DW; Witkowski ER; Bredella MA; Lauer GM; Corey KE; Dichtel LE
Growth Horm IGF Res; 2022 Aug; 65():101482. PubMed ID: 35780715
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children.
Cianfarani S; Inzaghi E; Alisi A; Germani D; Puglianiello A; Nobili V
J Pediatr; 2014 Jul; 165(1):92-8. PubMed ID: 24607243
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.
Runchey SS; Boyko EJ; Ioannou GN; Utzschneider KM
J Gastroenterol Hepatol; 2014 Mar; 29(3):589-96. PubMed ID: 24716226
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.
Donaghy AJ; Delhanty PJ; Ho KK; Williams R; Baxter RC
J Hepatol; 2002 Jun; 36(6):751-8. PubMed ID: 12044524
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
